II. Indications
III. Contraindications
- Severe Chronic Kidney Disease
- Risk of Magnesium accumulation
IV. Mechanism
- Magnesium Hydroxide is a rapid acting Antacid
- Aluminum hydroxide has delayed Antacid activity
V. Medications
- Aluminum Hydroxide and Magnesium Hydroxide Antacid (e.g. Mylanta)
- Available as 225 mg/200 mg per 5 ml suspension
- Adult
- FDA approved: 10 to 20 ml orally four times daily (max: 80 ml/day)
- Off label: 15 to 45 ml orally at 1 to 3 hours after meals and at bedtime
- Child (off Label)
- Newborn: 1 ml/kg/dose every 4 hours as neded
- Infants: 2 to 5 ml orally every 1 to 2 hours as needed
- Child: 5 to 15 ml orally every 1 to 2 hours as needed
- Aluminum Hydroxide and Magnesium Hydroxide and SimethiconeAntacid (e.g. Maalox)
- Available in various forms
- Maalox, Mylanta and other products add Simethicone as "anti-gas" formulations
- Simethicone offers little added benefit (beyond Placebo Effect)
- Adult (and age >=12 years)
- FDA approved: 10 to 20 ml orally four times daily (max: 80 ml/day)
- Off label: 15 to 45 ml orally at 1 to 3 hours after meals and at bedtime
- Child (off Label)
- Give 0.5 to 2 ml/kg/dose up to 5 to 15 ml orally after meals and at bedtime
- Aluminum Hydroxide and Magnesium Carbonate (Gaviscon)
- Available in various concentrations
- Also contains Alginic acid (forms foam barrier protection against acid)
- Regular Strength (95 mg/358 mg per 15 ml)
- Adult (FDA approved): 15 to 30 ml orally four times daily
- Child (off label): 5 to 15 ml orally after meals and at bedtime
VI. Adverse Effects
- Diarrhea
-
Constipation
- Aluminum decrease Constipation risk
-
Hypermagnesemia
- Rare outside severe renal disease (see contraindications above)
-
Metabolic Alkalosis
- May occur with chronic use of Gaviscon (due to alginic acid)
VII. Drug Interactions
- Interferes with absorption of other agents
- Aspirin (buffered, enteric)
- Diazepam
- Digoxin
- Fluoroquinolone
- Iron
- Isoniazid
- Tetracyclines
VIII. Pharmacokinetics
- Magnesium is well absorbed orally
- Rapid renal excretion
IX. Safety
- Pregnancy Category C
- Exception Gaviscon (unknown safety)
- Unknown safety in Lactation
X. Resources
- Aluminum Hydroxide and Magnesium Hydroxide and SimethiconeAntacid (e.g. Mylanta, DailyMed)
- Aluminum Hydroxide and Magnesium Hydroxide Antacid (e.g. Mylanta)
XI. References
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 90
- Hamilton (2020) Tarascon Pocket Pharmacopoeia